Data Foundry

Medical device recalls 2017

Cobas b 123 POC system The cobas b 123 POC system is a fully… — Class II medical device recall Z-1077-2017

Terminated recall by Roche Diagnostics Operations, Inc., reported 2017-02-01, distributed nationwide. under specific settings, an issue may occur during simultaneous Sensor Cartridge and Fluid Pack change on the

Recall numberZ-1077-2017
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmRoche Diagnostics Operations, Inc., Indianapolis, IN, United States
Recall initiated2015-09-03
Classified2017-01-23
Reported by FDA2017-02-01
Terminated2017-06-05
DistributedNationwide (US)
Quantity30
Reason classessoftware
Serial numbers11074, 1253, 1349, 1374, 1749, 1850, 1860, 1941, 2006, 2128, 2147, 2274, 2301, 2302, 2304, 2309, 2328, 2337, 2338, 2339, 2344, 2350, 2389, 2400, 2418 and 5 more

Product

Cobas b 123 POC system The cobas b 123 POC system is a fully automated POC system for whole blood in vitro measurement of pH, blood gases (B3G), electrolytes Nat, K+, iCaWt (ISE), hematocrit (THct), metabolites (Glu, Lac), total hemoglobin (tHb), hemoglobin derivatives (O2Hb, HHb, COT~b, MetHb), and oxygen saturation (SO2). In addition, the cobas b 123 POC system calculates derived parameters. It is dedicated for use in a Point-of-Care environment and laboratory. The integrated AutoQC module and the oximeter module are available as an option

Reason for recall

under specific settings, an issue may occur during simultaneous Sensor Cartridge and Fluid Pack change on the cobas b 123 <2> POC system and cobas b 123 <4> POC system. The issue occurs when the software function [AutoQC as follow-up] is configured to run all three levels of AutoQC only after a Fluid Pack change, but not after a Sensor Cartridge change. When both are changed simultaneously, starting with the Sensor Cartridge and followed by the Fluid Pack, the analyzer carries out only the follow-up actions associated with the Sensor Cartridge change after completing the change workflow. As a result, no follow-up AutoQC is performed and the three expected AutoQC measurements for the Fluid Pack change are not carried out. Without running quality control, there is a remote possibility that system issues would not be detected and wrong results would not be excluded on all parameters: pH, PO2, PCO2, Na+, K+, Ca++, Cl-, Glu, Lac, Hct, SO2, O2Hb, COHb, MetHb, HHb, and Bili.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1077-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.